[
  {
    "ts": "2025-12-01T14:00:00+00:00",
    "headline": "Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors",
    "summary": "PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (Nasdaq: PTCT),",
    "url": "https://finance.yahoo.com/news/cadrenal-therapeutics-appoints-dr-lee-140000544.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "81a396fe-33f9-384d-979b-39972340cf1a",
      "content": {
        "id": "81a396fe-33f9-384d-979b-39972340cf1a",
        "contentType": "STORY",
        "title": "Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors",
        "description": "",
        "summary": "PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (Nasdaq: PTCT),",
        "pubDate": "2025-12-01T14:00:00Z",
        "displayTime": "2025-12-01T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/9eea34a5d9b040ecc7de28fefc2640df",
          "originalWidth": 673,
          "originalHeight": 193,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qyh9zHHiQRo2ymIof8sVdw--~B/aD0xOTM7dz02NzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9eea34a5d9b040ecc7de28fefc2640df.cf.webp",
              "width": 673,
              "height": 193,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pu7dtNV9KCy60jTfn89Qrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9eea34a5d9b040ecc7de28fefc2640df.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cadrenal-therapeutics-appoints-dr-lee-140000544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cadrenal-therapeutics-appoints-dr-lee-140000544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVKD"
            },
            {
              "symbol": "PTCT"
            },
            {
              "symbol": "PTC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ESAIY"
            },
            {
              "symbol": "MESO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]